Showing results (1971-1980 of 2,694) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|June 27, 2025
Unveiling the incidences and trends of alveolar echinococcosis in Europe: a systematic review from the KNOW-PATH projectAdriano Casulli, Bernadette Abela, Daniele Petrone, et al.
The Lancet. Infectious Diseases|September 19, 2025
Artificial intelligence and infectious diseases: tackling antimicrobial resistance, from personalised care to antibiotic discoveryAlex Howard, Nada Reza, Peter L Green, et al.
The Lancet. Infectious Diseases|June 2, 2025
The (Re)-emerging And ePidemic Infectious Diseases (RAPID) Stigma Scales: a cross-outbreak scale development and pyschometric validation studyAmy Paterson, Kondwani K Mughogho, Ashleigh Cheyne, et al.
The Lancet. Infectious Diseases|February 15, 2024
Safety, pharmacokinetics, and efficacy of rifasutenizol, a novel dual-targeted antibacterial agent in healthy participants and patients in China with Helicobacter pylori infection: four randomised clinical trialsXiaojiao Li, Yusi Liu, Meng Wang, et al.
The Lancet. Infectious Diseases|February 11, 2024
Risk of death following chikungunya virus disease in the 100 Million Brazilian Cohort, 2015-18: a matched cohort study and self-controlled case seriesThiago Cerqueira-Silva, Julia M Pescarini, Luciana L Cardim, et al.
The Lancet. Infectious Diseases|February 11, 2024
The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling studyNora Schmit, Hillary M Topazian, H Magloire Natama, et al.
The Lancet. Infectious Diseases|February 11, 2024
Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling studyHyolim Kang, Megan Auzenbergs, Hannah Clapham, et al.
The Lancet. Infectious Diseases|February 10, 2024
Persistent SARS-CoV-2 infection: significance and implicationsHeather M Machkovech, Anne M Hahn, Jacqueline Garonzik Wang, et al.
The Lancet. Infectious Diseases|February 10, 2024
Case fatality risk among individuals vaccinated with rVSVΔG-ZEBOV-GP: a retrospective cohort analysis of patients with confirmed Ebola virus disease in the Democratic Republic of the CongoRebecca M Coulborn, Mathieu Bastard, Nicolas Peyraud, et al.
The Lancet. Infectious Diseases|March 21, 2024
Safety and immunogenicity of the co-administered Na-APR-1 and Na-GST-1 hookworm vaccines in school-aged children in Gabon: a randomised, controlled, observer-blind, phase 1, dose-escalation trialJeannot F Zinsou, David J Diemert, Jean Claude Dejon-Agobé, et al.
Pageof 270